GW BOTANICALS
GW Pharma Limited
Application Filed: 2018-04-24
Trademark Application Details
ABANDONED - EXPRESS
| Research |
OneLook
Acronym Finder
|
| Serial Number | 79237068 |
| Mark Drawing Code | 4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form |
| Attorney Docket Number | 438448 |
| Law Office Assigned | L80 |
| Employee Name | LOOK, JEFFREY J |
Timeline
| 2018-04-24 | Application Filed |
| 2018-09-11 | Location: TMEG LAW OFFICE 108 - EXAMINING ATTORNEY ASSIGNED |
| 2019-01-18 | Abandon |
| 2019-01-21 | Status: Dead/Abandoned |
| 2019-12-25 | Transaction Date |
Trademark Applicants & Owners
| Owner: |  GW Pharma Limited |
| Address | Sovereign House Histon, Cambridge CB24 9BZ GB |
| Legal Entity Type | Limited Liability Limited Partnership |
| Legal Entity State | GB |
Documents
Click the blue "Refresh" button to load certificates, specimines, application, and other documents.
Attorney of Record
Good, Services, and Codes
| International Codes: | 5 |
| U.S. Codes: | 006,018,044,046,051,052 |
| International Codes: | 31 |
| U.S. Codes: | 001,046 |
| Type Code | Type |
|---|---|
| GS0051 | Pharmaceutical, medical and veterinary preparations and substances; pharmaceutical preparations and substances for the treatment of epilepsy; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of convulsions, seizures, Dravet syndrome, Lennox-Gastaut syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures, generalized epilepsy with febrile seizures plus, Doose syndrome and chromosome disorders; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions; medicinal infusions for the treatment of epilepsy, convulsions and seizures; pure extracts of medicinal plants and herbs; foodstuffs for medicinal purposes; dietary supplements for humans and animals; dietetic food and substances adapted for medical or veterinary use; food for babies; herb teas for medicinal purposes; medications for the treatment of multiple sclerosis, pain associated with cancer, neuropathies and rheumatoid arthritis; medicines for the treatment of symptoms including pain, muscle spasticity and spasms, bladder problems and sleep disorders; medications for the treatment of conditions to which neuropathic pain is associated, including multiple sclerosis, cancer, spinal cord injury, physical trauma and peripheral neuropathy resulting from diabetes; medicines for the treatment of anorexia-cachexia, the result of cancer or AIDS, and nausea, and secondary vomiting due to chemotherapy treatments; pharmaceutical preparations with cannabinoids as active ingredient |
Trademark Filing History
| Description | Date | Event Coding |
|---|---|---|
| SN ASSIGNED FOR SECT 66A APPL FROM IB | 2018-07-19 | 1 REPR M: |
| NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-07-24 | 2 NWOS I:Incoming Correspondence |
| APPLICATION FILING RECEIPT MAILED | 2018-07-28 | 3 MAFR O:Outgoing Correspondence |
| ASSIGNED TO EXAMINER | 2018-08-14 | 4 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-08-21 | 5 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-08-22 | 6 RFCR E:E-Mail |
| ASSIGNED TO EXAMINER | 2018-08-27 | 7 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | 2018-08-29 | 8 RFWR P: |
| ASSIGNED TO EXAMINER | 2018-08-30 | 9 DOCK D:Assigned to Examiner |
| ASSIGNED TO EXAMINER | 2018-09-06 | 10 DOCK D:Assigned to Examiner |
| NON-FINAL ACTION WRITTEN | 2018-09-11 | 11 CNRT R:Renewal |
| NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | 2018-09-12 | 12 RFCR E:E-Mail |
| REFUSAL PROCESSED BY MPU | 2018-09-18 | 13 RFRR P: |
| NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | 2018-09-19 | 14 RFCS P: |
| REFUSAL PROCESSED BY IB | 2018-10-07 | 15 RFNT P: |
| TEAS EXPRESS ABANDONMENT RECEIVED | 2019-01-18 | 16 EXAR I:Incoming Correspondence |
| ABANDONMENT - EXPRESS MAILED | 2019-01-21 | 17 ABN1 O:Outgoing Correspondence |
| TEAS CHANGE OF CORRESPONDENCE RECEIVED | 2019-01-18 | 18 TCCA I:Incoming Correspondence |
| ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | 2019-01-22 | 19 MAB1 O:Outgoing Correspondence |
| NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | 2019-12-25 | 20 OPNR P: |
| NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | 2019-12-25 | 21 OPNS P: |
| NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | 2020-01-10 | 22 OPNX P: |
| FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | 2020-01-21 | 23 FICR P: |
| FINAL DISPOSITION NOTICE SENT TO IB | 2020-01-21 | 24 FICS P: |
| FINAL DECISION TRANSACTION PROCESSED BY IB | 2020-02-07 | 25 FINT P: |
| NEW REPRESENTATIVE AT IB RECEIVED | 2021-11-20 | 26 NREP P: |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 